Literature DB >> 10560026

The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias.

G M Sullivan1, J D Coplan, J M Kent, J M Gorman.   

Abstract

Over the past three decades of psychiatric research, abnormalities in the noradrenergic system have been identified in particular anxiety disorders such as panic disorder. Simultaneously, neuroscience research on fear pathways and the stress response have delineated central functions for the noradrenergic system. This review focuses on the noradrenergic system in anxiety spectrum disorders such as panic disorder, generalized anxiety disorder, and phobias for the purpose of elucidating current conceptualizations of the pathophysiologies. Neuroanatomic pathways that are theoretically relevant in anxiogenesis are discussed and the implications for treatment reviewed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10560026     DOI: 10.1016/s0006-3223(99)00246-2

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  47 in total

Review 1.  Toward an integrative understanding of social phobia.

Authors:  D Li; P Chokka; P Tibbo
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

2.  Differential behavioral sensitivity to carbon dioxide (CO2) inhalation in rats.

Authors:  Andrew Winter; Rebecca Ahlbrand; Devanshi Naik; Renu Sah
Journal:  Neuroscience       Date:  2017-01-11       Impact factor: 3.590

3.  Cardiovascular reactivity to mental stress is not affected by alpha2-adrenoreceptor activation or inhibition.

Authors:  Christine Philippsen; Melanie Hahn; Lars Schwabe; Steffen Richter; Jürgen Drewe; Hartmut Schachinger
Journal:  Psychopharmacology (Berl)       Date:  2006-11-17       Impact factor: 4.530

4.  Case report: bupropion-induced claustrophobia.

Authors:  Jodie V Malhotra; Cynthia A Mascarenas
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

5.  Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease.

Authors:  Gregory M Pontone; James R Williams; Karen E Anderson; Gary Chase; Susanne A Goldstein; Stephen Grill; Elaina S Hirsch; Susan Lehmann; John T Little; Russell L Margolis; Peter V Rabins; Howard D Weiss; Laura Marsh
Journal:  Mov Disord       Date:  2009-07-15       Impact factor: 10.338

Review 6.  Obstructive sleep apnea and severe mental illness: evolution and consequences.

Authors:  Wei-Chen Lin; John W Winkelman
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

7.  Neuroanatomical targets of reboxetine and bupropion as revealed by pharmacological magnetic resonance imaging.

Authors:  Sakthivel Sekar; J Van Audekerke; G Vanhoutte; A S Lowe; A M Blamire; A Van der Linden; T Steckler; M Shoaib; Marleen Verhoye
Journal:  Psychopharmacology (Berl)       Date:  2011-05-07       Impact factor: 4.530

8.  Methylmercuric chloride induces activation of neuronal stress circuitry and alters exploratory behavior in the mouse.

Authors:  J F Cooper; A W Kusnecov
Journal:  Neuroscience       Date:  2007-08-01       Impact factor: 3.590

9.  The effect of single-dose methylphenidate on the rate of error-driven learning in healthy males: a randomized controlled trial.

Authors:  Jonathon R Howlett; He Huang; Cédric M Hysek; Martin P Paulus
Journal:  Psychopharmacology (Berl)       Date:  2017-09-01       Impact factor: 4.530

10.  A HCO(3)(-)-dependent mechanism involving soluble adenylyl cyclase for the activation of Ca²⁺ currents in locus coeruleus neurons.

Authors:  Ann N Imber; Joseph M Santin; Cathy D Graham; Robert W Putnam
Journal:  Biochim Biophys Acta       Date:  2014-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.